Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F13A1 | P00488 | 3/20 | 0.32 |
| ▸ | TGM2 | P21980 | 3/20 | 0.32 |
| ▸ | TGM1 | P22735 | 3/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.30 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.30 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25040572 | 0.83 | MEN1 (0.31) | — | |
| SCHEMBL29314279 | 0.76 | CHRM2 (0.33) | USP2SMN1; SMN2HDAC1HDAC6CHRM2 | |
| SCHEMBL29314278 | 0.75 | HDAC1 (0.34) | USP2SMN1; SMN2HDAC1HDAC6CHRM2 | |
| SCHEMBL26538715 | 0.74 | HDAC1 (0.33) | USP2SMN1; SMN2HDAC1HDAC6CHRM2 | |
| SCHEMBL13847977 | 0.72 | CTSK (0.34) | USP2SMN1; SMN2HDAC1HDAC6 | |
| SCHEMBL31218507 | 0.70 | CHRM2 (0.44) | USP2SMN1; SMN2HDAC1HDAC6CHRM2 | |
| SCHEMBL25047142 | 0.70 | HDAC1 (0.34) | USP2SMN1; SMN2HDAC1HDAC6CHRM2 | |
| SCHEMBL18612694 | 0.70 | USP2 (0.32) | USP2SMN1; SMN2HDAC1HDAC6CHRM2 | |
| SCHEMBL4796997 | 0.69 | CHRM2 (0.43) | USP2SMN1; SMN2HDAC1HDAC6CHRM2 | |
| SCHEMBL18571170 | 0.69 | USP2 (0.40) | F13A1TGM2TGM1USP2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239745-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | Bilix Co., Ltd. (KR) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239745-A1 | METHOD FOR SYNTHESIZING BILIRUBIN | CYP7A1, UGT1A3, UGT1A1 | F13A1 987/4885TGM2 71/4885TGM1 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.